Navigation Links
Fusion presents low proliferation risk, experts conclude
Date:4/3/2012

American researchers have shown that prospective magnetic fusion power systems would pose a much lower risk of being used for the production of weapon-usable materials than nuclear fission reactors and their associated fuel cycle.

The researchers, from Princeton University, found that if nuclear fusion power plants are designed to accommodate appropriate safeguards, there is little risk of fissile materials being produced for weapons, either secretly or overtly.

Their results have been published today, 29 March, by IOP Publishing in the journal Nuclear Fusion.

In the study, the researchers undertook a quantitative assessment of the risks of proliferation the spreading of nuclear materials for use in weapons that could be associated with future magnetic fusion energy power systems in three different scenarios and compared them to the risks associated with nuclear fission.

Co-author of the study Alex Glaser summarizes: "We found that the proliferation risks from fusion are low compared with fission, assuming that IAEA safeguards are applied in both cases."

The three scenarios were: the clandestine production of weapon-usable material in an undeclared facility; the covert production of such material in a declared facility; and the production of material in a breakout scenario where the effort is not concealed.

Firstly, their findings showed that it is highly implausible that a small-scale nuclear fusion system could be built, and then operated, in a clandestine fashion to produce material for even one weapon in two years, due to the large size and power consumption of the facility that would be required; it would be clearly visible by, for example, the continuous power it would consume and ultimately have to dissipate at least some 40 MW.

In comparison, first-generation centrifuge plants used to produce highly enriched uranium for fission power plants are much less conspicuous and can be operated to produce material for one weapon per year with less than 0.5 MW of power, similar to many industrial operations.

The researchers then used a set of computer simulations to determine the quantities of weapons materials that could be produced with a commercial-size fusion power plant. While the production potential is significant in principle, it would be easy for inspectors to detect the covert production of weapon-usable material in a declared nuclear fusion power plant.

The final scenario examined was breakout, where weapon-usable material is produced as quickly as possible and without concealment. The researchers estimate that the minimum period that would be required after breakout to produce any weapon-usable material in a fusion power plant would be one to two months. They also note that fusion power plants require many supporting facilities, such as power inputs and cooling towers, which could potentially be shut down without risk of nuclear contamination, and therefore prevent material from being produced.


'/>"/>
Contact: Michael Bishop
michael.bishop@iop.org
01-179-301-032
Institute of Physics
Source:Eurekalert

Related biology technology :

1. CareFusion Announces 510(k) Clearance and U.S. Launch of New Advanced Electrodiagnostic System
2. Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION
3. New material for thermonuclear fusion reactors
4. CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
5. Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease
6. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
7. CareFusion Reports First Quarter Fiscal 2012 Results
8. Harvest Technologies Announces Initial Enrollment in Its REVIVE-1 Trial (REtrograde Vascular Infusion of BMAC to ImproVe Heart FailurE)
9. Practice Fusion Expands Executive Team with New VP of Marketing and Senior Business Development Director
10. Practice Fusion Invites Health Researchers to Analyze This! Contest on Windows Azure
11. Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... (PRWEB) , ... August 22, 2017 , ... Mettler-Toledo, one ... its V2630 vision inspection system . This turnkey system inspects labels, prints, and ... to the requirements of different production lines and extended as needed. , The ...
(Date:8/23/2017)... ... ... Having proven that its Disruptor™ technology is more than ... Cell Technologies® (GCT®), has turned its attention to the lucrative fruit sugar ... ushering in a new era of modern, cost effective and more natural processing ...
(Date:8/23/2017)... MN (PRWEB) , ... August 23, 2017 , ... ... by health systems and academic medical centers. The network provides members nationally scaled ... limited-distribution drugs and biologics and restrictive payer agreements so members can provide continuity ...
(Date:8/22/2017)... ... August 22, 2017 , ... KBioBox is pleased ... technology, the extended GUIDE-Seq ananlysis. KBioBox has adapted their core technology and direct ... scientists with easy to understand reports, extended indel analysis, and translocation analysis. , ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):